QUOTE AND NEWS
Benzinga  May 13  Comment 
SI Financial Group Inc. (NASDAQ: SIFI) shares lost 0.79% to create a new 52-week low of $10.72. SI Financial Group has a trailing twelve month loss margin of 1.97%. GenVec, Inc. (NASDAQ: GNVC) shares fell 29.40% to touch a new 52-week low of...
Benzinga  May 13  Comment 
Recon Technology, Ltd. (NASDAQ: RCON) Endo dipped 22.07% to $1.66 after the company released the third quarter fiscal year 2013 results. Star Bulk Carriers Corp. (NASDAQ: SBLK) shares fell 19.66% to $6.11. Star Bulk Carriers's...
StreetInsider.com  Mar 22  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/GenVec%2C+Inc.+New+%28GNVC%29+Posts+Q4+Loss+of+24cShare/8205626.html for the full story.
Benzinga  Dec 18  Comment 
Below are highlights from Benzinga's daily coverage of small cap securities making big moves: GenVec Shares of GenVec (NASDAQ: GNVC), the Gaithersburg, MD biopharmaceutical company, rose almost 30% Monday on 69 times average...
StreetInsider.com  Dec 17  Comment 
GenVec, Inc. (Nasdaq: GNVC) 36.9% HIGHER; announced that data were presented on its HSV vaccine program at the Keystone Symposia meeting on Immunological Mechanisms of Vaccination, which is taking place in Ottawa, Ontario from December 13 to...
Benzinga  Dec 17  Comment 
GenVec (NASDAQ: GNVC) surged 48.03% to $1.9392 at 9:45 am. GenVec reported that a single administration of its genetic vaccine was effective against HSV2 in two industry-accepted HSV disease models. Zions Bancorporation (NASDAQ: ZIONZ) shares...
StreetInsider.com  Nov 9  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/GenVec%2C+Inc.+New+%28GNVC%29+Posts+Q3+Loss+of+30cShare/7861109.html for the full story.
StreetInsider.com  Oct 2  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/GenVec+%28GNVC%29+Gets+%243.5M+Contract+from+NMRC+for+Malaria+Vaccine+Development/7763213.html for the full story.
FierceBiotech  Sep 25  Comment 
Back in the summer of 2010, Gaithersburg, MD-based GenVec ($GNVC) was forced to lay its card on the table and start hunting for a possible buyer after its lead program--a gene therapy for pancreatic cancer--failed to deliver in the clinic. But...
StreetInsider.com  Sep 25  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/GenVec+%28GNVC%29+Cuts+30%25+of+Workforce/7747859.html for the full story.





 




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki